TraceLink: Turning Pharma Serialization Data Into Faster Product Verification

Overview: How TraceLink’s Pharmaceutical Serialization & Traceability Platform Transforms Product Verification TraceLink supports pharmaceutical serialization and traceability through Product Information Manager – Product Verification, which checks serialized product identifiers and their status across supply-chain relationships. It addresses a bottleneck: variable volumes of verification requests can overwhelm manual processes, delay returned-product handling and complicate suspect-product investigations. […]

Feature Categories

Overview: How TraceLink’s Pharmaceutical Serialization & Traceability Platform Transforms Product Verification

TraceLink supports pharmaceutical serialization and traceability through Product Information Manager – Product Verification, which checks serialized product identifiers and their status across supply-chain relationships. It addresses a bottleneck: variable volumes of verification requests can overwhelm manual processes, delay returned-product handling and complicate suspect-product investigations. Checking identity and status together also helps flag identifiers associated with recalled or expired medicines during distribution.

The application publishes serialization records and product status to a secure, network-facing repository, allowing authorised parties to request verification without directly querying internal business systems. It checks packaging identifiers—including GTIN, lot number, expiration date and serial number—and returns a positive or negative verification result alongside available status information. Verification Router Service integration routes requests to the appropriate responder. The documented approach relies on structured data exchange and automated verification; the product page does not establish a machine-learning or AI component.

For operational workflows, this architecture can reduce manual lookup effort and shorten verification turnaround during returns processing or investigations. Separating external requests from internal repositories also limits transaction traffic reaching core systems. TraceLink describes support for high-volume operations and sub-second response requirements, although the page does not provide independently validated performance results.

Last checked on October 22, 2026: TraceLink announced new OPUS agent planning and governance capabilities on October 21, while its Product Verification page continues to describe automated serialised-identifier and product-status verification without specifying AI functionality.

What is TraceLink?

TraceLink provides pharmaceutical serialization and traceability software; its Product Information Manager – Product Verification application checks serialized product identifiers and status to support saleable-return verification and suspect-product investigations. It serves pharmaceutical manufacturers, repackagers, wholesale distributors, pharmacies, hospitals and other dispensers. Its technical approach combines a network-facing serialization repository with Verification Router Service integration and GS1 standards, returning identifier-verification results alongside statuses such as recalled or expired; AI functionality is not specified for this application.

Intended Use and Limitations

  • TraceLink publishes an ISO/IEC 27001:2022 information-security certificate; buyers should confirm its validity and scope against the services being procured.

  • TraceLink announced completion of a SOC 2 Type II and ISAE 3000 examination in March 2024; buyers should request the latest report and review its coverage and exceptions.

  • GS1 lists TraceLink in its solution-provider directory, providing external confirmation of its participation in the standards ecosystem used for pharmaceutical identification and traceability.

  • Product Verification supports GS1-based identifier checks and Verification Router Service integration for pharmaceutical saleable-return verification; these capabilities support DSCSA workflows rather than constitute FDA approval.

  • Product Verification returns recalled or expired status alongside identifier-verification results, distinguishing a matching serial number from a product’s distribution status.

  • TraceLink publishes a contractual Security Annex assigning responsibility for the confidentiality, integrity and availability of its services and internal IT systems.

  • TraceLink raised $93 million in Series D financing in August 2018; this is historical funding evidence, not a newly announced investment or proof of current financial strength.

  • In October 2026, TraceLink announced dedicated commercial, R&D and services teams for Track & Trace Compliance, indicating continued organisational investment in its pharmaceutical traceability business.

  • TraceLink’s October 2026 OPUS announcement describes inspectable, testable agent execution plans and versioned agent profiles; these governance capabilities relate to the broader AI platform, not specifically to Product Verification.

Follow HealthyData.Science on Google Search & AI

Get our latest healthcare and life science AI tool evaluations, regulatory updates, and buyer intelligence in your Google AI Overviews.

Add as Preferred Source

Get a neutral, no obligation view of whether this AI tool fits your portfolio

Avatar

Stephen

Founder of HealthyData.Science · 20+ years in life sciences compliance & software validation · MSc in Data Science & Artificial Intelligence.